Ac Immune

Developer of antibodies, small molecules, and vaccines for Alzheimer’s disease and other neurodegenerative diseases

placeLausanne, Vaud, Switzerland calendar_todayFounded 2003 groups156 employees language acimmune.com

Social engagement

Social engagement: 22.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital233%
Private equity117%
Other / undisclosed350%

Recent activity

15 May 2026
Leadership hire
CEO
12 May 2026
Leadership hire
Chief Executive Officer (CEO)
Coming soon